Cracking the code of drug delivery for advanced therapies

Cell and gene therapies are redefining medical possibilities, providing solutions for conditions once thought untreatable. Yet, the effective delivery of these therapies presents intricate challenges. In this video, Matt Parker, Head of Device Innovation at TTP, and Stuart Lowe, Head of Advanced Therapies at TTP, delve into the nuances of drug delivery mechanisms related to these advanced therapies. From encapsulation techniques to local targeting and logistical hurdles, they examine the practical advancements and multidisciplinary approaches needed to make these therapies accessible and impactful for patients worldwide.